食品科学 ›› 2025, Vol. 46 ›› Issue (12): 191-201.doi: 10.7506/spkx1002-6630-20241130-214

• 营养卫生 • 上一篇    下一篇

芜菁多糖对人源化小鼠胆汁酸代谢和肠道菌群的影响

张梦莹,提佳艺,李薇,毕凯悦,吴予涵,李颜博,赵宇,王伟   

  1. (新疆农业大学食品科学与药学学院,新疆?乌鲁木齐 830052)
  • 出版日期:2025-06-25 发布日期:2025-05-23
  • 基金资助:
    国家自然科学基金地区科学基金项目(32260586);新疆农业大学研究生校级科研创新计划项目(XJAUGRI2024012)

Effects of Brassica rapa L. Polysaccharides on Bile Acid Metabolism and Intestinal Microbiota in Humanized Mice

ZHANG Mengying, TI Jiayi, LI Wei, BI Kaiyue, WU Yuhan, LI Yanbo, ZHAO Yu, WANG Wei   

  1. (College of Food Science and Pharmacy, Xinjiang Agricultural University, ürümqi 830052, China)
  • Online:2025-06-25 Published:2025-05-23

摘要: 目的:探究芜菁多糖(Brassica rapa L. polysaccharide,BRAP1-1)在人源化小鼠模型中胆汁酸的代谢情况及其对肠道菌群的调节作用。方法:通过长时间灌胃人体粪便悬液建立人源化小鼠模型,再分别灌胃低(50 mg/kg,LB组)、高(200 mg/kg,HB组)剂量的BRAP1-1,以灌胃同体积生理盐水为空白对照(CK组),以灌胃菊粉为阳性对照(100 mg/kg,IN组)。3 周后,对小鼠体质量、脏器指数、血清中个别生化指标包括甘油三酯(triglyceride,TG)、总胆固醇(total cholesterol,TC)、丙二醛(malondialdehyde,MDA)水平以及小鼠结肠组织结构、粪便中胆汁酸组成、肠道菌群组成及短链脂肪酸含量进行检测并分析。结果:相对于CK组,其他3 组小鼠体质量均有所降低,小鼠胸腺指数均显著升高(P<0.05),HB组和IN组中小鼠脾脏指数显著高于CK组和LB组(P<0.05),表明BRAP1-1对小鼠的体质量及脏器指数有一定的影响。不同浓度的BRAP1-1能够降低TC、TG、MDA的水平从而调节脂质代谢。此外,BRAP1-1可提高结肠绒毛的发育程度,高剂量BRAP1-1的干预显著增加了小鼠粪便中总胆汁酸的水平,调节了肠道菌群组成,包括改变菌群α、β多样性,增加有益菌赖氨酸芽孢杆菌(Lysinibacillus)、Solibacillus、理研菌科_RC9肠群(Rikenellaceae_RC9_gut_group)、拟杆菌属(Bacteroides)相对丰度,减少有害菌密螺旋体属(Treponema)、黄杆菌属(Flavobacterium)的相对丰度。同时,粪便中乙酸、丙酸、丁酸、异丁酸含量也显著上调(P<0.05)。结论:BRAP1-1能够有效调节粪便中胆汁酸代谢组成及肠道菌群结构,提高肠道内有益短链脂肪酸的生成。本研究可为BRAP1-1促进肠道健康和胆汁酸代谢方面提供理论参考,为芜菁精深加工及相关功能性食品的开发提供新思路。

关键词: 芜菁多糖;人源化小鼠;胆汁酸代谢;肠道菌群

Abstract: Objective: To investigate the regulatory effect of Brassica rapa L. polysaccharides (BRAP1-1) on the metabolism of bile acids and the intestinal microbiota in a humanized mouse model. Methods: The mouse model was established by long-term oral administration of human fecal suspension, followed by intragastric administration of BRAP1-1 at low (50 mg/kg, LB) and high (200 mg/kg, HB) doses, the same volume of physiological saline as the blank control (CK) or inulin as the positive control (100 mg/kg, IN). After three weeks, body mass, organ indexes, serum biochemical indicators including triglyceride (TG), total cholesterol (TC), and malondialdehyde (MDA) levels, colonic tissue structure, bile acid composition in feces, intestinal microbiota composition, and short-chain fatty acids (SCFAs) contents were examined and analyzed. Results: Compared with the CK group, body mass decreased, and thymus index significantly increased in the three treatment groups (P < 0.05). Spleen index was significantly higher in the HB and IN groups than in the CK and LB groups (P < 0.05), indicating that BRAP1-1 had certain effects on mouse body mass and organ indices. Different concentrations of BRAP1-1 reduced the levels of TC, TG, and MDA, thereby regulating lipid metabolism. Furthermore, BRAP1-1 enhanced colonic villus development, and high-dose of BRAP1-1 intervention significantly increased the total bile acid level in mouse feces, modulated the intestinal microbiota composition by altering α and β diversity, increasing the relative abundance of beneficial bacteria such as Lysinibacillus, Solibacillus, Rikenellaceae_RC9_gut_group, and Bacteroides, and decreasing the relative abundance of harmful bacteria including Treponema and Flavobacterium. Concurrently, the contents of acetic acid, propionic acid, butyric acid, and isobutyric acid in feces were also significantly upregulated (P < 0.05). Conclusion: BRAP1-1 effectively regulates bile acid metabolism and the intestinal microbiota structure in mice, enhancing the production of beneficial SCFAs in the intestine. This study provides theoretical insights into the promotion of intestinal health and bile acid metabolism by BRAP1-1, offering new perspectives for the deep processing of B. rapa and the development of related functional foods.

Key words: Brassica rapa L. polysaccharides; humanized mice; bile acid metabolism; intestinal microbiota

中图分类号: